PMID: 40437949
Book your consultation now by either calling or using our website
Patients should be aware that some products sold as semaglutide may not contain the same active ingredient as FDA-approved semaglutide products and may be salt formulations, the FDA wrote
It Starts With a 15-Minute Conversation No pressure
Ozempic, Wegovy, Mounjaro, Zepbound - once positioned as diabetes and obesity innovations - are now being discussed in addiction clinics, neuroscientist labs, and policy circles for something far more consequential: the possibility that these drugs may blunt cravings for alcohol, nicotine, opioids, and other substances
Key Takeaways Retatrutide is being studied as a triple agonist that targets GIP, GLP-1, and glucagon receptors